2016 Q4 Form 10-Q Financial Statement

#000114420416137640 Filed on December 02, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2015 Q3
Revenue $4.113M $3.278M $3.278M
YoY Change 0.0% 0.0% 47.41%
Cost Of Revenue $2.130M $2.970M $2.590M
YoY Change -23.93% 14.67% 49.71%
Gross Profit $1.308M $684.7K $684.7K
YoY Change 0.0% 0.0% 38.73%
Gross Profit Margin 31.81% 20.88% 20.88%
Selling, General & Admin $1.009M $1.155M $1.154M
YoY Change -11.5% 0.09% 3.09%
% of Gross Profit 77.11% 168.68% 168.53%
Research & Development $200.0K $182.4K $147.1K
YoY Change 33.33% 23.94% -43.41%
% of Gross Profit 15.29% 26.63% 21.49%
Depreciation & Amortization $0.00 $10.00K $10.00K
YoY Change -100.0% 0.0% 0.0%
% of Gross Profit 0.0% 1.46% 1.46%
Operating Expenses $1.009M $1.337M $1.301M
YoY Change -21.79% 2.79% -5.67%
Operating Profit $299.5K -$652.6K -$616.3K
YoY Change 1530.57% 5.89% -30.42%
Interest Expense $20.34K $30.00K $210.0K
YoY Change -110.7% -85.71% -191.3%
% of Operating Profit 6.79%
Other Income/Expense, Net -$20.34K -$24.55K -$4.701K
YoY Change 185.05% 422.21%
Pretax Income -$550.0K -$60.00K -$4.701K
YoY Change 7608.48% 1176.32% -150.29%
Income Tax
% Of Pretax Income
Net Earnings -$174.2K -$411.3K -$411.3K
YoY Change 0.0% 0.0% -63.02%
Net Earnings / Revenue -4.23% -12.55% -12.55%
Basic Earnings Per Share
Diluted Earnings Per Share -$238.1K -$25.97K -$177.5K
COMMON SHARES
Basic Shares Outstanding 2.313M shares 2.313M shares 2.313M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $160.0K $140.0K $150.0K
YoY Change -30.43% -6.67% -94.62%
Cash & Equivalents $155.8K $141.8K $148.8K
Short-Term Investments
Other Short-Term Assets $200.0K $210.0K $340.0K
YoY Change -4.76% -38.24% -10.53%
Inventory $5.560M $5.000M $4.510M
Prepaid Expenses
Receivables $250.0K $200.0K $530.0K
Other Receivables $1.280M $1.690M $1.480M
Total Short-Term Assets $7.450M $7.240M $7.000M
YoY Change -6.61% 3.43% -8.3%
LONG-TERM ASSETS
Property, Plant & Equipment $53.11K $58.16K $90.00K
YoY Change -33.46% -35.38% -25.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $10.61M $11.33M $12.74M
YoY Change -12.18% -11.07% -8.48%
Other Assets $0.00 $0.00 $10.00K
YoY Change -100.0% -100.0% -75.0%
Total Long-Term Assets $10.73M $11.46M $12.90M
YoY Change -12.28% -11.15% -8.88%
TOTAL ASSETS
Total Short-Term Assets $7.450M $7.240M $7.000M
Total Long-Term Assets $10.73M $11.46M $12.90M
Total Assets $18.18M $18.70M $19.90M
YoY Change -10.04% -6.02% -8.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.540M $2.290M $1.310M
YoY Change 500.15% 74.81% 67.95%
Accrued Expenses $120.0K $110.0K $150.0K
YoY Change -60.0% -26.67% -48.28%
Deferred Revenue
YoY Change
Short-Term Debt $690.0K $660.0K $1.000M
YoY Change -57.67% -34.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.350M $3.070M $2.460M
YoY Change 3.84% 24.8% 129.91%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.350M $3.070M $2.460M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $3.350M $3.070M $2.460M
YoY Change 3.72% 24.8% 123.64%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $12.89M
YoY Change -0.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.83M $15.63M $17.44M
YoY Change
Total Liabilities & Shareholders Equity $18.18M $18.70M $19.90M
YoY Change -10.06% -6.03% -9.34%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income -$174.2K -$411.3K -$411.3K
YoY Change 0.0% 0.0% -63.02%
Depreciation, Depletion And Amortization $0.00 $10.00K $10.00K
YoY Change -100.0% 0.0% 0.0%
Cash From Operating Activities -$120.0K -$860.0K -$680.0K
YoY Change -83.78% 26.47% 300.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $100.0K $160.0K
YoY Change -87.8%
Cash From Investing Activities $100.0K $160.0K
YoY Change -87.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 30.00K 660.0K 570.0K
YoY Change -95.24% 15.79%
NET CHANGE
Cash From Operating Activities -120.0K -860.0K -680.0K
Cash From Investing Activities 100.0K 160.0K
Cash From Financing Activities 30.00K 660.0K 570.0K
Net Change In Cash 10.00K -40.00K -110.0K
YoY Change -98.59% -63.64% -35.29%
FREE CASH FLOW
Cash From Operating Activities -$120.0K -$860.0K -$680.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
64840 USD
CY2016Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
67075 USD
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
58158 USD
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71556 USD
CY2016Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
1070103 USD
CY2016Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
1808531 USD
CY2016Q3 uuu Funds Held By Factor
FundsHeldByFactor
0 USD
CY2016Q1 uuu Funds Held By Factor
FundsHeldByFactor
0 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
141792 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
362728 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-616301 USD
CY2016Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
51114 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-411302 USD
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4701 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-64066 USD
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-24549 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-28785 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-31945 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-300765 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-443247 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-181948 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18769 USD
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3278225 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
6214715 USD
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
182352 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
311484 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
596591 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1001007 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-570036 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1533523 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15633 USD
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
147128 USD
us-gaap Net Income Loss
NetIncomeLoss
-1188379 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12983 USD
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2312887 shares
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1154895 USD
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1153830 USD
uuu Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
4504825 USD
uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
142806 USD
us-gaap Gross Profit
GrossProfit
1567084 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1097963 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-278988 USD
us-gaap Net Income Loss
NetIncomeLoss
-453745 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-77433 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2312887 shares
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2268615 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2317616 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
319983 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
347431 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-279844 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-125460 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-20921 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-125460 USD
CY2015Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2015Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-31945 USD
uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
217597 USD
uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
-37307 USD
CY2016Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-4341 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
349100 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
99390 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-220936 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49427 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
148817 USD
us-gaap Interest Paid
InterestPaid
12983 USD
us-gaap Interest Paid
InterestPaid
28785 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
535233 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
911794 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
349100 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1001007 USD
CY2016Q1 uuu Working Capital
WorkingCapital
4463601 USD
CY2016Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2091000 USD
uuu Increase Decrease In Working Capital
IncreaseDecreaseInWorkingCapital
290140 USD
CY2016Q3 uuu Working Capital
WorkingCapital
4173461 USD
CY2016Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
1931000 USD
CY2016Q3 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
4833183 USD
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
5494185 USD
CY2016Q3 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
4359497 USD
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
5494185 USD
CY2016Q3 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
28010955 USD
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
31239508 USD
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
11705386 USD
CY2016Q3 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
13042873 USD
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
8273094 USD
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
57000 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2016-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
UNIVERSAL SECURITY INSTRUMENTS INC
dei Entity Central Index Key
EntityCentralIndexKey
0000102109
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
UUU
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2312887 shares
CY2016Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
263659 USD
CY2016Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
139985 USD
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887 shares
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887 shares
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887 shares
CY2016Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-113541 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
3704985 USD
us-gaap Line Of Credit Facility Borrowing Capacity Description
LineOfCreditFacilityBorrowingCapacityDescription
The Agreement for the assignment of accounts receivable expires on January 6, 2018 and provides for continuation of the program on successive two year periods until terminated by one of the parties to the Agreement. In accordance with the provisions of the Agreement, the Company may take advances equal to eighty percent (80%) of the uncollected non-recourse factored trade accounts receivable balance less applicable factoring commissions and may borrow up to fifty percent (50%) of eligible inventories subject to a borrowing limitation on inventory of $1,000,000.
CY2016Q3 us-gaap Line Of Credit
LineOfCredit
662991 USD
us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
bear interest at the prime commercial rate of interest, as published, plus two percent (Effective rate 5.50% atSeptember 30, 2016).
uuu Accounts Receivables Factoring Agreement Expiration Date
AccountsReceivablesFactoringAgreementExpirationDate
2018-01-06
uuu Accounts Receivables Factoring Agreement Term
AccountsReceivablesFactoringAgreementTerm
P2Y
CY2016Q3 us-gaap Assets
Assets
18701218 USD
CY2016Q1 us-gaap Assets
Assets
18510039 USD
uuu Increase Decrease In Funds Held By Factor
IncreaseDecreaseInFundsHeldByFactor
0 USD
uuu Increase Decrease In Funds Held By Factor
IncreaseDecreaseInFundsHeldByFactor
631906 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
631906 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-117882 USD

Files In Submission

Name View Source Status
0001144204-16-137640-index-headers.html Edgar Link pending
0001144204-16-137640-index.html Edgar Link pending
0001144204-16-137640.txt Edgar Link pending
0001144204-16-137640-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uuu-20160930.xml Edgar Link completed
uuu-20160930.xsd Edgar Link pending
uuu-20160930_cal.xml Edgar Link unprocessable
uuu-20160930_def.xml Edgar Link unprocessable
uuu-20160930_lab.xml Edgar Link unprocessable
uuu-20160930_pre.xml Edgar Link unprocessable
v451869_10q.htm Edgar Link pending
v451869_ex31-1.htm Edgar Link pending
v451869_ex31-2.htm Edgar Link pending
v451869_ex32-1.htm Edgar Link pending
v451869_ex99-1.htm Edgar Link pending